Trinity Biotech - 33 Year Stock Price History | TRIB
Historical daily share price chart and data for Trinity Biotech since 1992 adjusted for splits and dividends. The latest closing stock price for Trinity Biotech as of August 13, 2025 is 1.01.
- The all-time high Trinity Biotech stock closing price was 136.36 on January 16, 2014.
- The Trinity Biotech 52-week high stock price is 3.39, which is 235.6% above the current share price.
- The Trinity Biotech 52-week low stock price is 0.48, which is 52.5% below the current share price.
- The average Trinity Biotech stock price for the last 52 weeks is 1.02.
| Trinity Biotech Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 0.7366 | 0.9499 | 1.3600 | 0.5201 | 1.0103 | 14.78% |
| 2024 | 1.9634 | 2.1975 | 3.4600 | 0.7700 | 0.8802 | -58.97% |
| 2023 | 4.1112 | 5.3000 | 5.9000 | 1.8775 | 2.1450 | -56.67% |
| 2022 | 6.0935 | 7.1880 | 7.2000 | 4.6000 | 4.9500 | -30.77% |
| 2021 | 15.3580 | 18.0500 | 33.2000 | 7.1500 | 7.1500 | -62.47% |
| 2020 | 10.2946 | 5.3500 | 23.8500 | 3.1000 | 19.0500 | 268.69% |
| 2019 | 9.7142 | 11.5500 | 16.1000 | 3.4655 | 5.1670 | -54.87% |
| 2018 | 22.0923 | 25.9000 | 30.3000 | 10.7000 | 11.4500 | -55.10% |
| 2017 | 28.3044 | 34.8000 | 35.2000 | 22.5000 | 25.5000 | -26.30% |
| 2016 | 51.5808 | 58.4000 | 67.6500 | 31.5500 | 34.6000 | -41.16% |
| 2015 | 78.9764 | 89.6334 | 99.0165 | 54.1500 | 58.8000 | -32.00% |
| 2014 | 108.8977 | 121.8750 | 136.3570 | 79.2626 | 86.4728 | -29.70% |
| 2013 | 93.3023 | 70.9801 | 125.3980 | 70.4966 | 123.0000 | 76.41% |
| 2012 | 58.2187 | 48.1811 | 74.4614 | 46.9408 | 69.7230 | 43.57% |
| 2011 | 45.5158 | 39.2029 | 51.6634 | 38.0121 | 48.5627 | 20.36% |
| 2010 | 28.1498 | 18.2161 | 40.7600 | 17.5863 | 40.3478 | 118.07% |
| 2009 | 14.6881 | 7.5108 | 22.6699 | 4.8088 | 18.5023 | 152.50% |
| 2008 | 17.0043 | 30.1807 | 31.8294 | 5.7247 | 7.3276 | -76.51% |
| 2007 | 45.3212 | 40.2562 | 53.8124 | 26.1963 | 31.1887 | -20.54% |
| 2006 | 39.2482 | 37.6000 | 43.6911 | 32.4706 | 39.2487 | 5.02% |
| 2005 | 37.6072 | 53.6750 | 53.6750 | 28.7610 | 37.3710 | -31.08% |
| 2004 | 59.5896 | 97.2744 | 97.2744 | 46.3473 | 54.2245 | -46.95% |
| 2003 | 50.8460 | 26.5627 | 113.3770 | 22.8989 | 102.2210 | 313.33% |
| 2002 | 24.6597 | 27.4787 | 33.7072 | 17.0368 | 24.7308 | -11.18% |
| 2001 | 35.0465 | 41.2180 | 54.9573 | 20.8838 | 27.8450 | -32.44% |
| 2000 | 61.4169 | 32.0584 | 136.2480 | 32.0584 | 41.2180 | 33.33% |
| 1999 | 31.2940 | 26.9062 | 41.2180 | 21.1815 | 30.9135 | 28.57% |
| 1998 | 33.2693 | 37.7832 | 46.9427 | 17.1742 | 24.0438 | -33.33% |
| 1997 | 46.4506 | 42.3629 | 57.8197 | 29.7685 | 36.0657 | -16.00% |
| 1996 | 67.9619 | 66.4068 | 116.7840 | 41.2180 | 42.9354 | -39.52% |
| 1995 | 33.5123 | 35.4933 | 75.5663 | 17.1742 | 70.9865 | 87.88% |
| 1994 | 56.7340 | 70.9865 | 75.5663 | 33.2034 | 37.7832 | -45.00% |
| 1993 | 75.0983 | 75.5663 | 107.6250 | 50.3775 | 68.6966 | -11.76% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.020B | $0.062B |
| Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.035B | 26.74 |
| Boston Scientific (BSX) | United States | $152.087B | 36.27 |
| Stryker (SYK) | United States | $143.981B | 29.31 |
| EssilorLuxottica (ESLOY) | France | $137.519B | 0.00 |
| Medtronic (MDT) | Ireland | $118.029B | 16.74 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.517B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.032B | 24.56 |
| ResMed (RMD) | United States | $41.478B | 29.66 |
| GE HealthCare Technologies (GEHC) | United States | $33.973B | 15.97 |
| Agilent Technologies (A) | United States | $33.326B | 21.73 |
| Terumo (TRUMY) | Japan | $27.583B | 32.68 |
| Koninklijke Philips (PHG) | Netherlands | $25.989B | 17.19 |
| Insulet (PODD) | United States | $21.796B | 73.03 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.170B | 12.84 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.868B | 0.00 |
| Baxter (BAX) | United States | $12.317B | 9.52 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.240B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.436B | 27.31 |
| Lantheus Holdings (LNTH) | United States | $3.665B | 9.91 |
| Envista Holdings (NVST) | United States | $3.472B | 24.29 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.214B | 14.26 |
| Perrigo (PRGO) | Ireland | $3.174B | 7.93 |
| ICU Medical (ICUI) | United States | $2.723B | 18.54 |
| Haemonetics (HAE) | United States | $2.516B | 11.23 |
| LeMaitre Vascular (LMAT) | United States | $2.137B | 45.82 |
| Curaleaf Holdings (CURLF) | Canada | $1.824B | 0.00 |
| AtriCure (ATRC) | United States | $1.781B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.732B | 74.36 |
| QuidelOrtho (QDEL) | United States | $1.710B | 10.77 |
| AdaptHealth (AHCO) | United States | $1.287B | 18.35 |
| Phibro Animal Health (PAHC) | United States | $1.203B | 15.38 |
| BioLife Solutions (BLFS) | United States | $1.153B | 2406.00 |
| Acuren (TIC) | United States | $1.142B | 0.00 |
| Neogen (NEOG) | United States | $1.136B | 18.03 |
| Tilray Brands (TLRY) | Canada | $1.046B | 0.00 |
| InMode (INMD) | Israel | $0.899B | 8.32 |
| Valneva SE (VALN) | France | $0.800B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.772B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.685B | 0.00 |
| Surmodics (SRDX) | United States | $0.542B | 0.00 |
| ZimVie (ZIMV) | United States | $0.532B | 20.49 |
| SNDL (SNDL) | Canada | $0.531B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.511B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.465B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.439B | 15.10 |
| CeriBell (CBLL) | United States | $0.429B | 0.00 |
| Owens & Minor (OMI) | United States | $0.423B | 3.75 |
| Evolus (EOLS) | United States | $0.414B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.368B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.357B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.330B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.318B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.298B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.289B | 21.88 |
| Omeros (OMER) | United States | $0.258B | 0.00 |
| Cerus (CERS) | United States | $0.247B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.244B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.238B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.233B | 0.00 |
| Brainsway (BWAY) | Israel | $0.230B | 60.95 |
| Quanterix (QTRX) | United States | $0.221B | 0.00 |
| Organigram Global (OGI) | Canada | $0.213B | 0.00 |
| Exagen (XGN) | United States | $0.210B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.205B | 0.00 |
| High Tide (HITI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.187B | 15.40 |
| Biote (BTMD) | United States | $0.158B | 4.74 |
| FitLife Brands (FTLF) | United States | $0.158B | 19.40 |
| TriSalus Life Sciences (TLSI) | United States | $0.138B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.136B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.09 |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.067B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Safety Shot (SHOT) | United States | $0.054B | 0.00 |
| Zynex (ZYXI) | United States | $0.048B | 0.00 |
| Veru (VERU) | United States | $0.046B | 0.00 |
| Nephros (NEPH) | United States | $0.045B | 35.50 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.38 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Flora Growth (FLGC) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |